By Terry Chrisomalis Sarepta Therapeutics Inc On October 1, 2015 shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) ended the day up approximately 22 % …
Esperion Therapeutics Inc (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing a first-in-class, oral therapy for low-density lipoprotein cholesterol (LDL-C) lowering for the …
In a research report issued today, Chardan analyst Gbola Amusa maintained a Sell rating on shares of Esperion Therapeutics Inc (NASDAQ:ESPR), with a $36 price …
In a research report issued today, Chardan analyst Gbola Amusa reiterated a Sell rating on shares of Esperion Therapeutics Inc (NASDAQ:ESPR), and reduced the price …
In a research report released Friday, Chardan analyst Gbola Amusa reiterated a Sell rating on shares of Esperion Therapeutics Inc (NASDAQ:ESPR) and raised the …
Chardan analyst Gbola Amusa came out today with some commentary on Esperion Therapeutics Inc (NASDAQ:ESPR)’s top-line results from ETC-1002-014, a Phase 2 exploratory study evaluating the safety …
In a research report issued today, Chardan analyst Gbola Amusa reiterated a Sell rating on shares of Esperion Therapeutics Inc (NASDAQ:ESPR), while reducing the price target from …
Chardan analyst Gbola Amusa weighed in today with a negative report on Esperion Therapeutics Inc (NASDAQ:ESPR), reducing the price target to $55 (from $50), while reiterating …
